Sara Bonstein
2019 - OncoSec Medical
In 2019, Sara Bonstein earned a total compensation of $526.3K as Former Chief Financial Officer and Chief Operating Officer at OncoSec Medical, a 43% decrease compared to previous year.
Compensation breakdown
Bonus | $75,000 |
---|---|
Option Awards | $67,980 |
Salary | $368,846 |
Other | $14,510 |
Total | $526,336 |
Bonstein received $368.8K in salary, accounting for 70% of the total pay in 2019.
Bonstein also received $75K in bonus, $68K in option awards and $14.5K in other compensation.
Rankings
In 2019, Sara Bonstein's compensation ranked 11,616th out of 13,971 executives tracked by ExecPay. In other words, Bonstein earned more than 16.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,616 out of 13,971 | 17th |
Division Manufacturing | 4,707 out of 5,701 | 17th |
Major group Chemicals And Allied Products | 1,856 out of 2,200 | 16th |
Industry group Drugs | 1,599 out of 1,886 | 15th |
Industry Pharmaceutical Preparations | 1,183 out of 1,398 | 15th |
Source: SEC filing on April 30, 2020.
Bonstein's colleagues
We found one more compensation record of an executive who worked with Sara Bonstein at OncoSec Medical in 2019.
2019
Daniel O'Connor
OncoSec Medical